Regulation of postimplantation mouse embryonic growth by maternal vasoactive intestinal peptide.
Vasoactive intestinal peptide (VIP) is an identified regulator of growth in the embryonic day (E) 9-11 mouse. Mouse embryonic and extra-embryonic tissues were studied to identify the source of VIP at this critical time. VIP and mRNA was detected in the decidua/trophoblast at E8 and declined until E10, after which it was not detectable. VIP mRNA was not apparent in the embryo until E11-E12. At E9, cells in decidua had VIP as well as lymphocyte marker (delta and CD3) immunoreactivity. VIP binding sites were dense in the decidua/trophoblast at E6, which gradually decreased until E10. VIP binding sites were detected in embryonic neuroepithelium by E9. The transient presence of VIP binding sites and mRNA in the decidua/trophoblast correlate with the identified period of VIP growth regulation, when VIP mRNA is absent in the embryo. Therefore, these findings suggest that maternal decidual lymphocytes are the source of VIP that regulate early postimplantation embryonic growth.
Spong
C Y
CY
Section on Developmental and Molecular Pharmacology, NICHD, NIH, Bethesda, Maryland 20892, USA.
Lee
S J
SJ
McCune
S K
SK
Gibney
G
G
Abebe
D T
DT
Brenneman
D E
DE
Hill
J M
JM
D000818:Animals; D003656:Decidua / Q000502:physiology; D005314:Embryonic and Fetal Development / Q000502:physiology*; D005260:Female; D018507:Gene Expression Regulation, Developmental; D008431:Maternal-Fetal Exchange / Q000502:physiology*; D051379:Mice; D011247:Pregnancy; D014327:Trophoblasts / Q000502:physiology; D014660:Vasoactive Intestinal Peptide / Q000235:genetics / Q000502:physiology*
D014660:Vasoactive Intestinal Peptide